Diagnostic Accuracy of a Novel Chromogenic Direct Thrombin Inhibitor Assay: Clinical Experiences for Dabigatran Monitoring

Thrombosis and Haemostasis - Germany
doi 10.1160/th17-04-0280
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Georg Thieme Verlag KG

Related search

Effects of the Oral, Direct Thrombin Inhibitor Dabigatran on Five Common Coagulation Assays

Thrombosis and Haemostasis
Hematology
2011English

Therapeutic Promise of Dabigatran Etexilate, an Oral Direct Thrombin Inhibitor in a Preclinical Model of Colon Carcinogenesis

Clinical and Experimental Pharmacology
2018English

Multicenter Clinical Laboratory Evaluation of a Beta-Lactamase Disk Assay Employing a Novel Chromogenic Cephalosporin, S1.

Journal of Clinical Microbiology
Microbiology
1995English

Development of a Rapid and Sensitive Chromogenic Heparin Assay for Clinical Use

Pathophysiology of Haemostasis and Thrombosis
1993English

Dabigatran Inhibits Intravitreal Thrombin Activity

Acta Ophthalmologica
MedicineOphthalmology
2017English

New Oral Antithrombotics: Focus on Dabigatran, an Oral, Reversible Direct Thrombin Inhibitor for the Prevention and Treatment of Venous and Arterial Thromboembolic Disorders

Vascular Health and Risk Management
2012English

Diagnostic Accuracy of Xpert MTB/RIF Assay for Musculoskeletal Tuberculosis: A Meta-Analysis

Infection and Drug Resistance
Infectious DiseasesPharmacology
2017English

Diagnostic Accuracy and Turnaround Time of the Xpert MTB/RIF Assay in Routine Clinical Practice

PLoS ONE
Multidisciplinary
2013English

A Novel Assay for Studying the Involvement of Blood Cells in Whole Blood Thrombin Generation

Journal of Thrombosis and Haemostasis
MedicineHematology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy